Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Microtubule associated proteins as targets for anticancer drug development
Sadiya Khwaja, Kapil Kumar, Ranjana Das, et al.
Bioorganic Chemistry (2021) Vol. 116, pp. 105320-105320
Closed Access | Times Cited: 45

Showing 1-25 of 45 citing articles:

Paclitaxel and its semi-synthetic derivatives: comprehensive insights into chemical structure, mechanisms of action, and anticancer properties
Priyanka Sati, Eshita Sharma, Praveen Dhyani, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 14
Emerging role of microtubule-associated proteins on cancer metastasis
Onsurang Wattanathamsan, Varisa Pongrakhananon
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 35
Red‐Light Activation of a Microtubule Polymerization Inhibitor via Amide Functionalization of the Ruthenium Photocage
Ludovic Bretin, Yurii Husiev, Vadde Ramu, et al.
Angewandte Chemie International Edition (2023) Vol. 63, Iss. 5
Open Access | Times Cited: 15
Indole Derivatives: A Versatile Scaffold in Modern Drug Discovery—An Updated Review on Their Multifaceted Therapeutic Applications (2020–2024)
Xingyou Mo, Devendra Pratap Rao, Kirandeep Kaur, et al.
Molecules (2024) Vol. 29, Iss. 19, pp. 4770-4770
Open Access | Times Cited: 6
Microtubule Dysregulation in Prostate Cancer Metastasis to the Vertebrae
Alex Matov
(2025)
Closed Access
Synergistic strategies: histone deacetylase inhibitors and platinum-based drugs in cancer therapy
Ekta Shirbhate, Vaibhav Singh, Rakesh Kore, et al.
Expert Review of Anticancer Therapy (2025)
Closed Access
Design, Synthesis, and Molecular Docking Studies of 2‐Azetidinone‐Based Combretastatin A‐4 Analogues with Anticancer Activity
Nabel B. Ayrim, Asim A. Balakit, Souad J. Laftaa, et al.
ChemistrySelect (2025) Vol. 10, Iss. 6
Closed Access
Recent advancements in colchicine derivatives: Exploring synthesis, activities, and nanoformulations for enhanced therapeutic efficacy
Marialucia Rubicondo, Gianluca Ciardelli, Clara Mattu, et al.
Drug Discovery Today (2025), pp. 104312-104312
Closed Access
Design, synthesis, molecular docking and anticancer activity of benzothiazolecarbohydrazide–sulfonate conjugates: insights into ROS-induced DNA damage and tubulin polymerization inhibition
Najla Altwaijry, Mohamed A. Omar, Hanaa S. Mohamed, et al.
RSC Advances (2025) Vol. 15, Iss. 8, pp. 5895-5905
Open Access
Advances in epigenetic treatment of adult T-cell leukemia/lymphoma: a comprehensive review
Arash Letafati, Rabeeh Mehdigholian Chaijani, Fahime Edalat, et al.
Clinical Epigenetics (2025) Vol. 17, Iss. 1
Open Access
Anti-tumor pharmacology of natural products targeting mitosis
Manru Huang, Caiyan Liu, Yingying Shao, et al.
Cancer Biology and Medicine (2022) Vol. 19, Iss. 6, pp. 1-28
Open Access | Times Cited: 22
Tubulin degradation: Principles, agents, and applications
Yifan Zhang, Jiao Huang, Weixin Zhang, et al.
Bioorganic Chemistry (2023) Vol. 139, pp. 106684-106684
Closed Access | Times Cited: 14
The vinyl sulfone motif as a structural unit for novel drug design and discovery
You‐Cai Xiao, Fen‐Er Chen
Expert Opinion on Drug Discovery (2023) Vol. 19, Iss. 2, pp. 239-251
Closed Access | Times Cited: 11
Microtubule‐associated proteins and enzymes modifying tubulin
Nannan Peng, Fumihiko Nakamura
Cytoskeleton (2023) Vol. 80, Iss. 3-4, pp. 60-76
Open Access | Times Cited: 10
mTOR inhibitor introduce disitamab vedotin (RC48-ADC) rechallenge microtubule-chemotherapy resistance in HER2-low MBC patients with PI3K mutation
Ye Hu, Fengxi Chen, Siwen Sun, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 3
Design, synthesis and biological evaluation of novel podophyllotoxin derivatives as tubulin-targeting anticancer agents
Yujin Guo, Beibei Chen, Jinxiu Guo, et al.
Pharmaceutical Biology (2024) Vol. 62, Iss. 1, pp. 233-249
Open Access | Times Cited: 3
2-Methoxydiol derivatives as new tubulin and HDAC dual-targeting inhibitors, displaying antitumor and antiangiogenic response
Moran Sun, Jinling Qin, Yingying Kang, et al.
Bioorganic Chemistry (2022) Vol. 120, pp. 105625-105625
Closed Access | Times Cited: 16
In vitro and in silico antiproliferative potential of isolated flavonoids constitutes from Pistacia integerrima
Abdur Rauf, Umer Rashid, Zuneera Akram, et al.
Zeitschrift für Naturforschung C (2024) Vol. 79, Iss. 7-8, pp. 187-193
Open Access | Times Cited: 2
Role of motor proteins in human cancers
Iman Ibrahim, Amany Balah, Abrar Gomaa Abd Elfattah Hassan, et al.
Saudi Journal of Biological Sciences (2022) Vol. 29, Iss. 12, pp. 103436-103436
Open Access | Times Cited: 12
Design, synthesis and tubulin polymerization inhibition activity of newly synthesized hydrazone-linked to combretastatin analogues as potential anticancer agents
Hany M. Abd El‐Lateef, Rasha Mohammed Saleem, Mohammed A. Bazuhair, et al.
Journal of Molecular Structure (2023) Vol. 1292, pp. 136190-136190
Closed Access | Times Cited: 7
New Schiff Base–TMB Hybrids: Design, Synthesis and Antiproliferative Investigation as Potential Anticancer Agents
Najiah M. Alyamani
Symmetry (2023) Vol. 15, Iss. 3, pp. 609-609
Open Access | Times Cited: 5
Design and synthesis of novel 3-amino-5-phenylpyrazole derivatives as tubulin polymerization inhibitors targeting the colchicine-binding site
Yang Yang, Yan Cao, Jingwen Yu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 267, pp. 116177-116177
Closed Access | Times Cited: 1
Design of novel isoxazole derivatives as tubulin inhibitors using computer-aided techniques: QSAR modeling, in silico ADMETox, molecular docking, molecular dynamics, biological efficacy, and retrosynthesis
Youness Moukhliss, Yassine Koubi, Imran Zafar, et al.
Journal of Biomolecular Structure and Dynamics (2024), pp. 1-12
Closed Access | Times Cited: 1
TUBB, a robust biomarker with satisfying abilities in diagnosis, prognosis, and immune regulation via a comprehensive pan-cancer analysis
Zaifu Zhu, Wei Zhang, Shaohu Huo, et al.
Frontiers in Molecular Biosciences (2024) Vol. 11
Open Access | Times Cited: 1
Synthetic Peptides Induce Human Colorectal Cancer Cell Death via Proapoptotic Pathways
Felipe Pantoja Mesquita, Francisco L. de Oliveira, Emerson Lucena da Silva, et al.
ACS Omega (2024) Vol. 9, Iss. 42, pp. 43252-43263
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top